Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc
Journal website http://www.neurores.org

Original Article

Volume 9, Number 1-2, March 2019, pages 8-13


Seropositivity in Myasthenia Gravis as a Predictor of Response to Therapeutic Plasma Exchange

Tables

Table 1. Comparison for Each Parameter in the QMGS Before and After TPE Treatment
 
QMGS parameterGroup N = 62MeanStd. deviationStd. error meantSig. (2-tailed)
QMGS: Quantitative Myasthenia Gravis Scale; TPE: therapeutic plasma exchange; PRE: before TPE; POST: after TPE. P > 0.05: non-significance difference, P < 0.05: significant difference; P < 0.01: highly significant difference.
Frustrated by my conditionPRE3.32100.543760.060423.8010.0001
POST2.97530.611870.06799
Troubles using my eyesPRE3.43210.568730.063198.1000.0001
POST2.55560.790570.08784
Trouble eatingPRE3.50620.572790.063648.910
POST2.58020.739330.082150.0001
Limited social activities because of MGPRE3.04940.545460.060614.6550.0001
POST2.62960.600930.06677
Limited abilities to enjoy hobbies and funPRE3.17280.608070.067564.5640.0001
POST2.70370.697220.07747
Trouble meeting the needs of my familyPRE3.08640.636350.070714.8540.0001
POST2.60490.626080.06956
Have to make plans around my conditionPRE2.87650.533450.059274.0360.0001
POST2.51850.593950.06599
My skills and job status have been negatively affectedPRE3.39510.664810.073873.7530.0001
POST2.98770.715780.07953
Difficulty in speakingPRE3.28400.596540.066288.4720.0001
POST2.37040.765580.08506
Trouble in drivingPRE3.02470.547160.060808.6360.0001
POST2.22220.632460.07027
Depressed about my conditionPRE3.39510.491910.054664.4530.0001
POST2.87760.520540.06544
Trouble in walkingPRE2.76540.553890.061548.8370.0001
POST1.96300.600930.06677
Have trouble getting around public placesPRE2.97530.446520.049616.3230.0001
POST2.43210.631230.07014
Feel overwhelmed by my conditionPRE3.02470.473690.052632.6660.008
POST2.81480.527050.05856
Have trouble performing my personal grooming needsPRE2.17280.542910.060323.5040.001
POST1.87650.533450.05927

 

Table 2. Comparison Between TPE Group and Non-TPE Group Regarding QMGS Score Initially and After 1 Month of Treatment
 
Non-TPE group, N = 16TPE group, N = 62Group differenceP valueSig.
QMGS: Quantitative Myasthenia Gravis Scale; TPE: therapeutic plasma exchange; NS: non significant; S: significant; HS: highly significant; IQR: inter-quartile range. aindependent t-test; bMann-Whitney test.
Initial QMGS scoreMean ± SD24.14 ± 2.0025.66 ± 3.85-1.537a0.125NS
Range21 - 2718 - 34
QMGS score after 1 monthMean ± SD26.37 ± 3.2018.05 ± 4.147.828a< 0.0001HS
Range22 - 3211 - 30
QMGS changeMedian (IQR)8 (0 - 14.27)-26.68 (-41.36 to -17.67)-6.406b< 0.0001HS
Range-4.17 - 38.1-58.06 - 0

 

Table 3. Relation Between AChR Antibodies of the Studied Patients and QMGS Score
 
AchR antibodiesGroup differenceP valueSig.
Sero-negative group, N = 11Sero-positive group, N = 51
NS: non significant; S: significant; HS: highly significant; AChR: presence of acetylcholine receptor; IQR: inter-quartile range; QMGS, Quantitative Myasthenia Gravis Scale. aIndependent t-test; bMann-Whitney test.
Initial QMGS scoreMean ± SD22.33 ± 3.0326.48 ± 3.75-4.124a0.000HS
Range18 - 2719 - 34
QMGS score after 1 monthMean ± SD18.27 ± 2.4318.00 ± 4.450.218a0.829NS
Range15 - 2211 - 30
QMGS changeMedian (IQR)-14.88 (-26.08 to -9.61)-32 (-42.31 to -20.83)-3.516b0.000HS
Range-44.44 - 0-58.06 - 0
Test value4.6749.938---
P value0.0000.000